GPIHBP1 Antibodies

Santa Cruz Biotechnology delivers a wide array of GPIHBP1 monoclonal antibodies for research focused on understanding GPIHBP1's role in lipid metabolism and cardiovascular health. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GPIHBP1, or glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1, plays a crucial role in the transport of triglyceride-rich lipoproteins and is essential for lipid homeostasis. The function of GPIHBP1 is vital for the clearance of triglyceride-rich lipoproteins from circulation, making it an important target for research related to metabolic disorders and cardiovascular diseases. Understanding GPIHBP1 mechanisms can provide insights into potential therapeutic strategies for managing lipid-related conditions. Research utilizing GPIHBP1 monoclonal antibodies continues to reveal new aspects of lipid metabolism and transport. Investigating GPIHBP1 function helps advance our understanding of cardiovascular health and disease progression. GPIHBP1 research supported by Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific knowledge in lipid metabolism and cardiovascular research.